Edwards Lifesciences Corp at JPMorgan Healthcare Conference Transcript

Jan 09, 2024 / 07:15PM GMT
Robert Justin Marcus - JPMorgan Chase & Co, Research Division - Analyst

Great. Thanks, everyone. If you could take your seats, we can get started. I'm Robbie Marcus, the med tech analyst at JPMorgan. Really happy to bring in our new session with Edwards Lifesciences. I want to introduce CEO, Bernard Zovighian, do a presentation, then we'll join you on stage for Q&A.

Bernard J. Zovighian - Edwards Lifesciences Corporation - CEO & Director

Thank you. Thank you, Robbie. Good morning, everyone. We truly value your interest in Edwards. I'm super excited about sharing our vision for 2024 and long term. I'm going to share also a couple of things that happened since our investor conference in December. I'm going to make some forward-looking statements involving risk. They are filed with the SEC and they are on our website. Using non-GAAP financial measure, also same on our website and filed with the SEC.

So as you may have heard at our recent investor conference in December, we are entering a new era of structural heart innovation. So what do we

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot